Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 104776
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.104776
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.104776
Figure 3 Receiver operating characteristic curve analysis using the serum exosomal miR-17-92 cluster for distinguishing patients with gastric cancer from healthy controls.
A: Receiver operating characteristic curve (ROC) curve for miR-17; B: ROC curve for miR-18; C: ROC curve for miR-19a; D: ROC curve for miR-92; E: ROC curve for miR-17 + miR-18; F: ROC curve for miR-17 + miR-18 + miR-19a + miR-92. AUC: The area under the curve.
- Citation: Han Y, Guo XP, Zhi QM, Xu JJ, Liu F, Kuang YT. Circulating exosomal miR-17-92 cluster serves as a novel noninvasive diagnostic marker for patients with gastric cancer. World J Gastrointest Oncol 2025; 17(5): 104776
- URL: https://www.wjgnet.com/1948-5204/full/v17/i5/104776.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i5.104776